期刊文献+

微流控流体动力聚焦技术制备的脂质体及靶向乳腺癌的新策略

Preparation of Liposomes by Microfluidic Hydrodynamic Focusing Technology and Application in the Treatment of Breast Cancer
原文传递
导出
摘要 脂质体是具有磷脂双分子层结构的囊泡,能够装载多种药物,并在靶向肿瘤的药物递送中具有独特优势,但其在可控制备与靶向效率方面面临重要挑战。本综述聚焦微流控流体动力聚焦制备脂质体的方法,介绍了不同种类的微流控芯片,以及相关过程参数对脂质体性能的影响。另外,着重介绍了脂质体在靶向乳腺癌方面的不同递送策略,为脂质体研究提供一种先进的制备技术与新颖的靶向策略。 Liposomes are vesicles with a phospholipid bilayer structure capable of loading a wide range of drugs and offer unique advantages in targeted tumor drug delivery.However,they face significant challenges in controllable preparation and targeting efficiency.This review focuses on the preparation of liposomes by microfluidic hydrodynamic focusing techniques,introducing different types of microfluidic chips,and the influences of relevant process parameters on liposome properties.Further,different delivery strategies of liposomes for targeting breast cancer are highlighted to provide an advanced preparation technique and novel targeting strategy for liposome research.
作者 金毅 苏明珠 郭静 吕松伟 蔡志强 JIN Yi;SU Mingzhu;GUO Jing;LYU Songwei;CAI Zhiqiang(School of Pharmacy,Changzhou University,Changzhou 213164;Changzhou Wujin People’s Hospital,Changzhou 213017)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第6期801-810,共10页 Chinese Journal of Pharmaceuticals
关键词 脂质体 微流控术 流体动力聚焦 乳腺癌 靶向治疗 liposome microfluidics hydrodynamic focusing breast cancer targeted therapy
  • 相关文献

参考文献3

二级参考文献43

  • 1Baker, J., Ajani, J., Scotte, F., Winther, D., Martin, M., Aapro, M.S., yon Minckwitz, G., 2009. Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs., 13(1):49-59. [doi:10.1016/j.ejon.2008.10.003].
  • 2Bissery, M.C., 1995. Preclinical pharmacology of docetaxel. Eur. J. Cancer, 31($4):S1-$6. [doi:10.1016/0959-8049 (95)00357-O].
  • 3Chu, C.J., Dijkstra, J., Lai, M.Z., Hong, K., Szoka, F.C., 1990. Efficiency of cytoplasmic delivery by pH-sensitive lipo-somes to cells in culture. Pharm. Res., 7(8):824-834. [doi:l 0.1023/A:1015908831507].
  • 4Connor, J., Huang, L., 1985. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J. Cell Biol., 101(2):582-589. [doi: 10.1083/jcb. 101.2.582].
  • 5Ducat, E., Deprez, J., Peulen, O., Evrard, B., Piel, G., 2010. Cellular uptake of long-circulating pH sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells. Drug Discov. Today, 15(23-24):1083. [doi: 10.1016/j.drudis.2010.09.362].
  • 6Engels, F.K., Sparreboom, A., Mathot, R.A., Verweij, J., 2005. Potential for improvement of docetaxel-based chemo- therapy: a pharmacological review. Br. J. Cancer, 93(2):173-177. [doi: 10.1038/sj.bjc.6602698].
  • 7Friedenberg, W.R., Graham, D., Greipp, P., Blood, E., Winston, R.D., 2003. The treatment of multiple myeloma with docetaxel (an ECOG study). Leuk. Res., 27(8): 751-754. [doi:l 0. ] 016IS0145-2 ] 26(02)00344-2].
  • 8Gelmon, K., 1994. The taxoids: paclitaxel and docetaxel. Lancet, 344(8932):1267-1272. [doi:10.1016/S0140-6736 (94)90754-4].
  • 9Grant, I~.S., Wiliiams, T.L., Zahaczewsky, M., Dicker, A.P., 2003. Comparison of antiangiogenic activities using pa- clitaxel (taxol) and docetaxel (taxotere). Int. J. Cancer, 104(1): 121-129. [doi: 10.1002/ijc. 10907].
  • 10Hair, W.N., Rublin, E., Alli, E., Goodin, S., 2007. Tubulin targeting agents. Update on Cancer Therapeutics., 2(1):1-18. [doi:10.1016/j.uct.2006.10.001].

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部